Only once, in 1989, the laboratory was dedicated hepatitis C virus, and the disease was officially recognized as viral, began the search for drugs to treat it in this format. The most successful in combating the disease until recently was considered (applied) the combination of interferon and ribavirin, which is:
- Required a long course of treatment (6 to 12 months).
- had a number of contra-indications, limitations and side effects for the patient.
- Percentage of completely cured barely reached 80% of clinical cases.
- had a number of contra-indications, limitations and side effects for the patient.
- Required a long course of treatment (6 to 12 months).
And only in 2014 have been developed, clinically tested and became mass produced drug, consisting of Sofosbuvir and Daclatasvir (for more information on the clinical characteristics on the supplier's website https://gepalive.ru/) He is appointed by the treating doctor in the format of the course (1 tablet per day) for various durations depending on the complexity and stage of the disease. The result – the treatment of chronic hepatitis C in 98% of patients treated.
High cost drugs
the Cost of foreign exchange set of Sofosbuvir and Daclatasvir, manufactured at the enterprises of its developers is so high that it is unaffordable for most domestic patients with a diagnosis of chronic hepatitis C. fortunately, today launched mass production of its generics. The drug is produced according to the official patent for pharmaceutical enterprises with only production facilities:
- No maintenance costs and for laboratory researches.
- Cheap labor is the so-called 3 countries.
- No maintenance costs and for laboratory researches.
reduce the cost of the drug on the order. Buy generic daclatasvir and sofosbuvir in Moscow today it is possible in an online format through the official website of the supplier. For advice on online provides an option for a call-back medical professional, which can be used by anyone without any prior registration and confirmation.
